Home » Newsletters » BioWorld Science

BioWorld Science

May 9, 1997

View Archived Issues

Company Profile: Mercury Therapeutics

Alexion issued two patents covering technology for xenotransplantation products

Viracept now available in Canada through expanded access program

FDA approves Mylan's generic extended-release diltiazem

Roche gains access to combinatorial libraries

Aquila's QS-21 enhances immune response of DNA vaccines in preclinical studies

Smith & Nephew to evaluate DynaGen's Orthodyn

Cel-Sci's HGP-30 AIDS vaccine shows recognition of major HIV subtypes

Nanogen and Becton Dickinson enter diagnostic collaboration

Dermik introduces combination acne therapy in South Africa

Lilly and Scios AD collaboration

Orphan Medical's medicated chewing gum reduces stomach levels of H. pylori

CytoMed initiates phase II trials of CMI-392

Medtronic and Cephalon to copromote Intrathecal Baclofen Therapy

Nippon Shinyaku prepares improved ciclosporin derivatives

Antiparasitic depsipeptides from Meiji Seika

Wakunaga prepares novel antibacterial agents

Lilly discloses selective beta3-agonists

Bradykinin antagonists from Fujisawa

Improved analgesic/antiinflammatory urea derivatives disclosed by Novartis

MS&D reports potent and selective 5-HT1Dalpha agonists

Cinchonine shown to reverse multidrug resistance

Preclinical and preliminary clinical data reported for LU-103793

ONYX-015 demonstrates in vitro and in vivo efficacy

Preclinical data for ZD-1839, an EGF tyrosine kinase inhibitor

BM-92.0700: a promising anticancer clinical candidate

Novel EGF receptor TK inhibitor described by Mitsubishi

Natural cancer immunotherapeutic discovered by Yonsei University researchers

New class of topo I inhibitors designed for oral administration

Anti-HBV/anti-HIV L-nucleoside analogue described

Fujisawa's Prograf cleared by FDA for use in kidney transplantation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...